Entities / Company
Lyell Immunopharma (United States).
company in South San Francisco, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 21
What's happening
Gone quiet
No new reports in 90+ days-
FDA granted RMAT and Fast Track designations to Lyell Immunopharma.Some support3 reports1 development inside
-
Lyell Immunopharma is securing private placement funds to support its continued growth.Some support1 report
-
LYL314, a next-generation CAR T-cell therapy, was identified as a product of Lyell Immunopharma.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Lyell Immunopharma (United States) this week
News at the entities that move Lyell Immunopharma (United States) most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Lyell Immunopharma (United States)